Behavioral Alcohol Responses (BAR) Study

Sponsor
Carnegie Mellon University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03467191
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH), University of Pittsburgh (Other), Penn State University (Other)
400
1
2
65.5
6.1

Study Details

Study Description

Brief Summary

This study aims to identify risk factors that prospectively predict alcohol problems in young adults.

Condition or Disease Intervention/Treatment Phase
Early Phase 1

Detailed Description

The vast majority of alcohol use takes place in social settings, yet nearly all human experimental work has administered alcohol to individuals in isolation. This study will examine the effects of alcohol in social groups and test whether these responses predict the escalation of alcohol use and development of alcohol use disorder symptoms. Participants will also complete smartphone surveys querying subjective responses to alcohol in their daily lives.

N=400 male and female young adults will participate in a laboratory session with two other participants and will consume either a moderate dose of alcohol or placebo beverage. Subjective and objective responses to alcohol will be assessed. Participants will also complete surveys on their smartphones; these will occur during drinking episodes and at random times throughout the day. Follow-up sessions will occur at 6-months and 12-months, to collect information about drinking habits and potential alcohol-related problems.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Predicting Alcohol Use and Alcohol Use Disorder Symptoms From Subjective Responses to Alcohol in a Laboratory Social Setting
Actual Study Start Date :
Feb 13, 2018
Actual Primary Completion Date :
Jul 15, 2022
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Alcohol Beverage

Moderate dose of alcohol (target BAC .08%)

Drug: Alcohol
target BAC .08%

Placebo Comparator: Placebo Beverage

Other: Placebo
placebo beverage

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline Alcohol Use at 12-months [12-month follow-up]

    Timeline Follow Back Method

  2. Change from Baseline Alcohol Use Disorder Symptoms at 12-months [12-month follow-up]

    Structured Clinical Interview for DSM-5

Secondary Outcome Measures

  1. Subjective Responses to Alcohol [1 day (laboratory session) and 21-day ambulatory assessment period]

    Participants will indicate how they feel after drinking alcohol using the Brief-Biphasic Alcohol Effects Scale, which is a 6-item scale assessing alcohol's acute stimulant and sedative effects (0-10 scale, with higher scores indicating higher values).

  2. Social Bonding [1 day (laboratory session)]

    Facial expressions of emotions using Paul Ekman's Facial Action Coding System (FACS). The duration of AUs associated with positive and negative affect will be coded.

  3. Social Bonding [1 day (laboratory session)]

    Perceived Group Reinforcement Scale, which is a 12-item scale assessing self-reported bonding (1-9 scale, with higher scores indicating more bonding).

  4. Mood [1 day (laboratory session)]

    8-item Mood Measure, which is an 8-item scale assessing mood items from each of the four quadrants of the affective circumplex (with higher scores indicating more felt emotion).

  5. Alcohol Use [21-day ambulatory assessment period]

    Quantity of standard drinks consumed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 29 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 21 to 29 years of age

  • currently drinks alcohol

  • owns a smartphone

Exclusion Criteria:

[Exclusion criteria are masked from public viewing until data collection is complete. Please contact project managers.]

Contacts and Locations

Locations

Site City State Country Postal Code
1 Carnegie Mellon University Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • Carnegie Mellon University
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • University of Pittsburgh
  • Penn State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kasey Creswell, Associate Professor, Carnegie Mellon University
ClinicalTrials.gov Identifier:
NCT03467191
Other Study ID Numbers:
  • STUDY2017_00000346
  • R01AA025936
First Posted:
Mar 15, 2018
Last Update Posted:
Jul 26, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 26, 2022